Atlas Trials

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

Clinical trial NCT04739072 · RECRUITING

Trial details

NCT number
NCT04739072
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Study type
OBSERVATIONAL
Colorectal AdenocarcinomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8Stage IIB Colorectal Cancer AJCC v8Stage IIC Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIIC Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v6Stage IVA Colorectal Cancer AJCC v8
Start date
2019-11-22
Primary completion
2028-12-31
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.